LANXESS Aktiengesellschaft (LXS) Fair Value & Analysis
Basic Materials · DE · Market cap €1.4B · ISIN DE0005470405
What is LANXESS Aktiengesellschaft really worth?
Below-average quality, trading 53% below our fair value of €33.08.
Risks
For context
Fair value as of: Aug 29, 2026
From 4 valuation models · updated 7 days ago
Share price −7.2% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (€18.69). The market is more pessimistic than our downside scenario.
- A fairly wide model range (€18.69 to €47.47) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 29, 2026.
How to read this chart
60‑month range €11.58 – €60.80 · fair‑value band €18.69 – €47.47 · the €15.52 price screens below the €33.08 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 29, 2026.
Analysis
LANXESS Aktiengesellschaft (LXS) currently trades at €15.52, while our model-based Fair Value estimate is €33.08, implying the stock looks roughly 53.1% undervalued today. The Quality Score stands at 42/100 (below-average quality), in the Basic Materials sector. Bull case: the Multiples group reads highest at a median of €41.63 per share, and 2 of the 4 models we run sit above the €15.52 price. Bear case: the Asset-Based group reads lowest at €27.12, and 2 of the 4 models stay below the price. Evidence for this calculation is medium.
Over the trailing twelve months, LANXESS Aktiengesellschaft generated revenue of €5.4B at a net margin of −12.1%. Revenue declined 13.9% year over year. It earns a return on equity of −16.8%. Net debt stands at €2.1B. Fundamentals as of Aug 29, 2026
Our scenario range runs from €18.69 (bear case) to €47.47 (bull case); at €15.52, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 44% below its 52-week high and 42% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at −58% fair-value upside, at 113%, LXS screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 4 models by family
Widest divergence: Multiples (€41.63) versus Dividend Discount (€0.9700). Highest evidence: Gordon GGM (69).
Notify me when LXS reaches fair value
Put LXS on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 29, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 41 · Market factors (momentum, volatility) 30
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates.
Full company description
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries. It also offers additives, lubricants, flame retardants, plasticizers, and bromine derivatives for various rubber, plastic and paint, electrical/electronics, and construction industries. In addition, the company provides basic and fine chemicals, organometallics, and inorganic pigments for the coloring of construction materials, as well as paints and coatings. It serves the energy, natural resources, industrial applications, nutrition, health, consumer goods, agriculture, animal health, construction, chemicals, and mobility industries. LANXESS Aktiengesellschaft was founded in 1863 and is headquartered in Cologne, Germany.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
LANXESS Aktiengesellschaft reported revenue of €5.7B in FY2025 versus €7.6B in FY2021, a compound −6.9%/yr. Reported net income was −€577M in FY2025.
Watch LXS: get an alert when its fair value changes →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- LANXESS Targets Deeper Cuts, Deleveraging as Chemical Markets Stay Weak
- Lanxess AG (LNXSF) (Q2 2026) Earnings Call Highlights: Operational Turning Point Drives ...
- LANXESS Aktiengesellschaft Q2 Earnings Call Highlights
- Chromium Salt Market Size, Share & Trends Analysis Report, 2026-2033 Published — 85-Page Study Profiling BASF, Lanxess, and 8 Other Key
Peer Group
Specialty Chemicals · 695 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Chemicals median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 29, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $485.35 | $222.03 | −54% |
| The Sherwin-Williams Company SHW | $344.86 | $143.38 | −58% |
| Ecolab Inc ECL | $286.75 | $96.18 | −66% |
| Air Products and Chemicals, Inc APD | $308.09 | $122.14 | −60% |
| Givaudan SA GIVN | CHF 3,282 | CHF 1,498 | −54% |
| Wanhua Chemical Group 600309 | ¥77.66 | ¥68.03 | −12% |
| 500820 500820 | ₹2,757 | ₹557.43 | −80% |
| Novozymes A/S NSISB | kr 456.40 | kr 169.99 | −63% |
| Asian Paints Limited ASIANPAINT | ₹2,630 | ₹696.23 | −74% |
| PPG Industries, Inc PPG | $114.22 | $71.31 | −38% |
Compare LANXESS Aktiengesellschaft with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is LANXESS Aktiengesellschaft (LXS) overvalued or undervalued?
What is the fair value of LXS?
What is the quality score of LXS?
What is the revenue of LANXESS Aktiengesellschaft (LXS)?
What is the net profit margin of LXS?
Does LANXESS Aktiengesellschaft pay a dividend?
Watch LANXESS Aktiengesellschaft in the live analysis
One click puts LANXESS Aktiengesellschaft on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.